NASDAQ:LEXX | Free Cash Flow | Lexaria Bioscience Corp.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-10-31 to 2025-11-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-11-30-$984,098.00$0.00-$984,098.00
2025-08-31-$2.64M$1.00-$2.64M
2024-11-30-$2.73M$24,645.00-$2.75M
2024-08-31-$1.89M$43,014.00-$1.93M
2023-11-30-$1.18M$0.00-$1.18M
2023-08-31-$1.62M$0.00-$1.62M
2022-11-30-$1.25M$20,500.00-$1.27M
2022-08-31-$1.18M$4.00-$1.18M
2021-11-30-$1.17M$42,375.00-$1.21M
2021-08-31-$1.11M
2020-11-30-$809,533.00$0.00-$809,533.00
2020-08-31-$639,346.00$0.00-$639,346.00
2019-11-30-$555,079.00$0.00-$555,079.00
2019-08-31-$736,609.00$9,522.00-$746,131.00
2018-11-30-$564,314.00$122,832.00-$687,146.00
2018-08-31-$837,060.00
2017-11-30-$520,321.00
2017-08-31-$353,335.00$0.00-$353,335.00
2016-11-30-$100,987.00$0.00-$100,987.00
2016-08-31-$260,767.00$0.00-$260,767.00
2015-11-30-$208,950.00$3,094.00-$212,044.00
2015-08-31-$580,889.00$0.00-$580,889.00
2014-11-30-$173,214.00$0.00-$173,214.00
2014-08-31$453,681.00
2014-01-31-$91,886.00
2013-11-30$124,028.00
2013-10-31$74,274.00
2013-01-31$62,489.00
2012-10-31$203,607.00
2012-01-31-$45,518.00
2011-10-31$292,858.00
2011-01-31-$71,117.00
2010-10-31-$173,163.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-08-31-$10.45M$24,646.00-$10.48M
2024-08-31-$4.96M$43,014.00-$5M
2023-08-31-$5.88M$33,748.00-$5.91M
2022-08-31-$4.88M$49,192.00-$4.93M
2021-08-31-$3.99M
2020-08-31-$2.62M$0.00-$2.62M
2019-08-31-$3.01M$646,183.00-$3.65M
2018-08-31-$2.52M
2017-08-31-$1.55M$0.00-$1.55M
2016-08-31-$660,856.00$3,094.00-$663,950.00
2015-08-31-$1.5M$0.00-$1.5M
2014-08-31-$515,817.00
2013-10-31$321,000.00
2012-10-31$135,943.00
2011-10-31$109,837.00
2010-10-31-$330,336.00